Andrew Cunningham

Peroxisome proliferator-activated receptor gamma agonist effect on rheumatoid arthritis : a randomized controlled trial

A. Shintani, A. Bian, A. Oeser, 2013 .

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial

C. Stein, A. Shintani, A. Bian, 2013, Arthritis Research & Therapy.

GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.

C. Stein, A. Wood, M. Muszkat, 2009, Pharmacogenomics.

Genotype and risk of major bleeding during warfarin treatment.

B. Gage, D. Roden, J. Denny, 2014, Pharmacogenomics.

Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy

A. Shintani, A. Bian, A. Oeser, 2014, Arthritis & Rheumatology.